Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin GB0009252882
Ticker GSK.L
Company GLAXOSMITHKLINE
Currency £
Price
Aware Investor Index (AII) 1,341.8922
Recommendation STRONG BUY
P/E 16.83
ROE 100.00 %
Capitalization 94,985,212,820 $
Dividend Yield 5.39 %
P/S 2.43
AII Position 5
P/E Position 207
ROE Position 23
Capitalization Position 75
Dividend Yield Position 77
Sales 30,186,000,000 £
10-Year Average Earnings 4,356,000,000 £
Shares Outstanding 4,941,000,000
Equity -68,000,000 £
Dividend per Share 0.8 £
Industry Pharmaceutical
Country Great Britain
GLAXOSMITHKLINE Investor Relations Web Site http://www.gsk.com/investors.html







Sales:

YEAR MONTH AMOUNT
2017 12 30,186,000,000.00 £
2016 12 27,889,000,000.00 £
2015 12 23,923,000,000.00 £
2014 12 23,006,000,000.00 £
2013 12 26,505,000,000.00 £

Earnings:

YEAR MONTH AMOUNT
2017 12 1,532,000,000.00 £
2016 12 912,000,000.00 £
2015 12 8,422,000,000.00 £
2014 12 2,756,000,000.00 £
2013 12 5,436,000,000.00 £
2012 12 4,499,000,000.00 £
2011 12 5,208,000,000.00 £
2010 12 2,961,000,000.00 £
2009 12 6,283,000,000.00 £
2008 12 5,551,000,000.00 £

Equity:

YEAR MONTH AMOUNT
2017 12 -68,000,000.00 £
2016 12 1,124,000,000.00 £
2015 12 5,114,000,000.00 £
2014 12 4,263,000,000.00 £
2013 12 7,812,000,000.00 £
2012 12 6,747,000,000.00 £
2011 12 8,827,000,000.00 £
2010 12 9,745,000,000.00 £
2009 12 10,742,000,000.00 £
2008 12 8,318,000,000.00 £

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 4,941,000,000
2016 12 4,909,000,000
2015 12 4,888,000,000
2014 12 4,865,000,000
2013 12 4,919,000,000
2012 12 4,913,000,000
2011 12 5,099,000,000
2010 12 5,128,000,000
2009 12 5,108,000,000
2008 12 5,226,000,000

 












Bloomberg News for GLAXOSMITHKLINE:



Google News for GLAXOSMITHKLINE:

Weston Business Review - 1 day ago
Glaxosmithkline Plc (GSK.L): Stock Price Performance (1.55%) in ...
Taking a closer look at shares of Metal Tiger Plc (MTR.L), we have noted that the stock price has risen 1.55% over the last 4-weeks. Zooming in ...
Stock Voice
Glaxosmithkline Plc (GSK.L) Share Price Heads Below Balance Step
Glaxosmithkline Plc (GSK.L) shares are on close watch heading into the middle of the week as the price has moved below the Balance Step ...
Hawthorn Caller
Is the 0.061312 Book to Market Valuation Worth a Look for ...
GlaxoSmithKline plc (GSK.L) is yielding a market ratio of 0.061312. The book to market ratio is a relative valuation ratio which divides the book ...
The FinExaminer
GlaxoSmithKline plc (GSK.L)'s One Month Price Index Holds at ...
GlaxoSmithKline plc (GSK.L) presently has a 6 month price index of 0.980653. The price index is calculated by dividing the current share price ...
Richland Standard - 9 hours ago
Is Money Flowing into Glaxosmithkline Plc (GSK.L)? Twiggs MF in ...
Traders will be closely monitoring shares of Glaxosmithkline Plc (GSK.L) as the Twiggs Money Flow indicator has touched above the zero line, ...
Martin Business Telegraph - 3 hours ago
Signal Watch : Wilder Moving Average is Below Simple MA on ...
Following the trading signals on shares of Glaxosmithkline Plc (GSK.L), we note that the twenty one day Wilder Moving Average is currently ...
The Hi New Ulm
GlaxoSmithKline plc (GSK.L) Quant Signals Under Scrutiny as EV ...
GlaxoSmithKline plc (GSK.L) has a current EV or Enterprise Value of 110281313.9. The EV displays how the market assigns value to a firm as ...
Martin Business Telegraph - 1 day ago
Investor Toolbox: A Look at the 2189 ERP5 For GlaxoSmithKline plc ...
The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of GlaxoSmithKline plc (GSK.L) is 2189.
Stock Voice - 3 days ago
Sizing up Glaxosmithkline Plc (GSK.L)'s Quarterly Performance ...
Glaxosmithkline Plc (GSK.L) has ended the quarter in the red, yielding negative results for the shares at they ticked -0.37% over that time frame.
Lakeland Observer - 1 day ago
GlaxoSmithKline plc (GSK.L) Stands at 0.353952
Traders watching the movements of GlaxoSmithKline plc (GSK.L) might be interested in how the quality ratios are stacking up for the shares.


Back